论文部分内容阅读
我院自1983年以来,采用肝素配伍外源性核糖核酸治疗肝病患者114例,共计注射肝素20.340例次。疗程最长达150天以上。本文就肝素的并发症报告如下:临床资料治疗对象男性103例,女性11例,年龄:16～25岁52例,26～35例45例、36～45岁14例、46～55岁3例,全部病例均由肝活检证实为肝硬化16例,慢性活动性乙型肝炎98例。肝素来源全部病例均采用上海生化制药厂生产的肝素钠注射液。给药方法肝素钠6000单位溶于10％葡萄
Our hospital since 1983, the use of heparin and exogenous ribonucleic acid treatment of liver disease in 114 patients, a total of 20.340 cases of injection of heparin. The course of up to 150 days or more. This article reports the complications of heparin are as follows: Clinical data of 103 males and 11 females, age: 16 to 25 years in 52 cases, 26 to 35 cases in 45 cases, 36 to 45 years in 14 cases, 46 to 55 years in 3 cases , All cases were confirmed by liver biopsy cirrhosis in 16 cases, chronic active hepatitis B in 98 cases. All cases of heparin source used in Shanghai Biochemical Pharmaceutical Factory heparin injection. Method of administration Heparin sodium 6000 units dissolved in 10% grape